The US and China made progress during their latest trade talks in Spain, particularly on TikTok and drug-related money laundering.
Continue Reading
Washington and Beijing are racing to secure a Trump-Xi visit by the end of the year, but Trump has conditioned a visit on a trade deal being reached.
China has emerged as a leader in advanced self-driving technology, with local companies now offering an experience comparable to Tesla’s FSD in the US.
Cambricon has become a market favorite amid the recent A-share rally, supported by increased profitability and China’s booming AI demand.
The PBOC may have shifted its stance on the exchange rate, signaling a preference for a stronger RMB against the USD.
Chinese novel drug developers have rallied in 2025, driven by headline out-licensing deals.
China’s real estate market correction has erased RMB 44-80trn in household wealth from peak, leaving most post-2016 homebuyers sitting on losses.
The humanoid robot industry is pursuing an “entertainment first” approach for now, but the ultimate goal is viability in more practical applications.